20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
2025 London Landmarks Half Marathon
Ditch the bus tour and grab your trainers! This much loved event takes in all the best the capital has to offer… The London Landmarks Half Marathon is a closed road, central London run and is the only half marathon to go through both the...
Diabetes dual agonist drugs for Parkinson’s
Glucagon-like peptide 1 receptor (or GLP-1R) agonists are recognised as a frontline treatment for diabetes. Researchers have recently been developing the next generation of treatment for diabetes which target GLP-1R and another protein called gastric inhibitory polypeptide (or GIP) at the same time. These combination…
Hospitality Finder Christmas event raises over £30k for Parkinson’s research
On Thursday 2 December, Corporate entertainment company Hospitality Finder kicked off the festive season with their Green Room Live Christmas Event at The Kia Oval cricket ground, supporting Dallaglio Rugby Works and Cure Parkinson’s.
GCase and Parkinson’s: a new perspective
Recently researchers have provided new insights into how small defects in a region of DNA called the GBA gene could be affecting cell biology leading to Parkinson’s.
GCase: Mutants matter?
Tiny genetic variations in a region of DNA called the GBA gene are associated with an increased risk of developing Parkinson’s. The information in the GBA gene provides the instructions for making an enzyme (called GCase) which is involved with waste disposal inside of cells. Individuals with Parkinson’s who carry a […]